Thermo Fisher Scientific acquires Henogen from Novasep for €725m to expand viral vector manufacturing capabilities

Thermo Fisher Scientific has completed the acquisition of Henogen, a viral vector manufacturing business previously owned by Groupe Novasep, for €725 million in cash. This ... Read More